Listing Compliance. The Company is in compliance in all material respects with the requirements of the Nasdaq for continued listing of the Common Stock thereon; the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or the listing of the Common Stock on the Nasdaq, nor has the Company received any notification that the Commission or the Nasdaq is contemplating terminating such registration or listing; the transactions contemplated by this Agreement will not contravene the rules or regulations of the Nasdaq;
Appears in 2 contracts
Samples: Underwriting Agreement (Runway Growth Finance Corp.), Underwriting Agreement (Runway Growth Finance Corp.)
Listing Compliance. The Company is in compliance in all material respects with the requirements of the Nasdaq Global Select Market (“Nasdaq”) for continued listing quotation of the Common Stock thereon; the . The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or the listing quotation of the Common Stock on the Nasdaq, nor has the Company received any notification that the Commission or the Nasdaq is contemplating terminating such registration or listing; the quotation. The transactions contemplated by this Agreement will not contravene the rules or and regulations of Nasdaq. The Company will comply with all requirements of Nasdaq with respect to the Nasdaq;issuance of the Shares.
Appears in 1 contract
Listing Compliance. The Company is in compliance in all material respects with the requirements of the Nasdaq The NASDAQ Stock Market (“NASDAQ”) for continued listing of the Common Stock thereon; on the NASDAQ Capital Market. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or the listing of the Common Stock on the NasdaqNASDAQ Capital Market, nor has the Company received any notification that the Commission or the Nasdaq NASDAQ is contemplating terminating such registration or listing; the . The transactions contemplated by this Agreement will not contravene the applicable rules or and regulations of the Nasdaq;NASDAQ.
Appears in 1 contract
Listing Compliance. The Company is in compliance in all material respects with the requirements of the Nasdaq NASDAQ for continued listing of the Common Stock common stock of the Company thereon; the . The Company has taken no action designed to, or likely to have the effect of, terminating terminate the registration of the Common Stock common stock of the Company under the Exchange Act or the listing of the Common Stock common stock of the Company on the NasdaqNASDAQ, nor as of the date of this Agreement has the Company received any written notification that the Commission SEC or the Nasdaq NASDAQ is contemplating terminating such registration or listing; the transactions contemplated by this Agreement will not contravene the rules or regulations of the Nasdaq;.
Appears in 1 contract
Samples: Subscription Agreement (Albany Molecular Research Inc)
Listing Compliance. The Company is in material compliance in all material respects with the requirements of the Nasdaq NASDAQ for continued listing of the Common Stock Company’s common stock thereon; the . The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock its common stock under the Exchange Act or the listing of the Common Stock its common stock on the NasdaqNASDAQ, nor has the Company received any notification that the Commission SEC or the Nasdaq NASDAQ is contemplating terminating such registration or listing; the . The transactions contemplated by this Agreement will not contravene in any material respect the rules or and regulations of the Nasdaq;NASDAQ.
Appears in 1 contract